thanks danhoff - appreciate the response.
Obviously, I got it the wrong way around because from your post it sounds like AT1 are the product developers and its licensed to "partners" like Accessbio and Lumos. Sounds more compelling.
Pity about the revenue target but if the product is any good that's just a short term glitch. Depends on maturity and number of competitors tho.
I'll take your advice and do some reading - thanks
- Forums
- ASX - By Stock
- AT1
- Media Update
Media Update, page-427
-
- There are more pages in this discussion • 1,419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $13.10M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $121 | 6.039K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1749919 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 32000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1749919 | 0.020 |
3 | 695000 | 0.019 |
4 | 462414 | 0.018 |
3 | 65000 | 0.017 |
2 | 37500 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 32000 | 1 |
0.022 | 53184 | 2 |
0.023 | 200000 | 1 |
0.024 | 113559 | 2 |
0.025 | 9000 | 1 |
Last trade - 12.49pm 06/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |